Počet záznamov: 1
myasthenia gravis, novorodenecká
SYS d020941 LBL 00000cx--j2200000---45-- 005 20240119200331.3 100 $a 19991103asloy0103----ba0 152 $b mesh 250 $a myasthenia gravis, novorodenecká $x BL $x CF $x CI $x CL $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo 300 1-
$a 2000 $8 eng 300 1-
$a Myasthenia Gravis (1965-1999) $8 eng 330 1-
$a A disorder of neuromuscular transmission that occurs in a minority of newborns born to women with myasthenia gravis. Clinical features are usually present at birth or develop in the first 3 days of life and consist of hypotonia and impaired respiratory, suck, and swallowing abilities. This condition is associated with the passive transfer of acetylcholine receptor antibodies through the placenta. In the majority of infants the myasthenic weakness resolves (i.e., transient neonatal myasthenia gravis) although this disorder may rarely continue beyond the neonatal period (i.e., persistent neonatal myasthenia gravis). (From Menkes, Textbook of Child Neurology, 5th ed, p823; Neurology 1997 Jan;48(1):50-4) $8 eng 450 $a Antenatal Myasthenia Gravis $5 e $8 eng 450 $a Neonatal Myasthenia Gravis $5 e $8 eng 450 $a myasténia gravis, antenatálna $5 e $8 slo 450 $a myasthenia gravis, prenatálna $5 e $8 slo 450 $a myasthenia gravis, neonatálna $5 e $8 slo 450 $a myasthenia gravis, u novorodencov $5 e $8 slo 675 $a 616.831.8-009.17-053.31 686 $a C10.114.656.650 686 $a C10.668.758.725.650 686 $a C20.111.258.500.650 750 $a Myasthenia Gravis, Neonatal $8 eng 801 -0
$a US $b DNLM $c 19991103 801 -2
$a SK $b BA006 $c 20021118 801 -2
$a SK $b BA006 $c 20201215 980 $x M
Počet záznamov: 1